Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab

Lancet Oncol. 2006 Sep;7(9):778-80. doi: 10.1016/S1470-2045(06)70864-6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / administration & dosage*
  • Brain Neoplasms / cerebrospinal fluid
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / therapy*
  • Female
  • Humans
  • Injections, Spinal
  • Meningeal Neoplasms / cerebrospinal fluid
  • Meningeal Neoplasms / drug therapy*
  • Meningeal Neoplasms / secondary
  • Receptor, ErbB-2 / immunology
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab